Reduced circulating B-lymphocytes and altered B-cell compartments in patients suffering from chronic myeloid leukaemia undergoing therapy with Imatinib

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Hematological oncology 2015-12, Vol.33 (4), p.250-252
Hauptverfasser:	Carulli, Giovanni, Baratè, Claudia, Marini, Alessandra, Ottaviano, Virginia, Cervetti, Giulia, Fontanelli, Giulia, Guerrini, Francesca, Arici, Roberta, Guerri, Valentina, Di Paolo, Antonello, Polillo, Marialuisa, Ferreri, Maria I., Galimberti, Sara, Petrini, Mario
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic Agents - administration & dosage Antineoplastic Agents - therapeutic use B-Lymphocytes - cytology B-Lymphocytes - metabolism Humans Imatinib Mesylate - administration & dosage Imatinib Mesylate - therapeutic use Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology Middle Aged Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!